LSU Researchers' Noo
LSU Researchers' Nootkatone Studies Could Lead to Prevention of Lyme Disease
09 avr. 2024 10h00 HE | LSU College of Engineering
BATON ROUGE, La., April 09, 2024 (GLOBE NEWSWIRE) -- Thanks to a $550,000 National Science Foundation Partnership for Innovation grant—the largest NSF PFI grant ever awarded to LSU—LSU Chemical...
outpace logo.png
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting
04 avr. 2024 07h00 HE | Outpace Bio
Seattle, WA, April 04, 2024 (GLOBE NEWSWIRE) -- Outpace Bio, a cell therapy company that is solving the major barriers to curing solid tumors with unrivaled AI-powered protein design, today...
website-logo (2).png
Epigenetics Market Predicted to Garner USD 12.7 Billion By 2033, At CAGR 19.2% | Exclusive Report by Marketresearch.biz
16 janv. 2024 03h58 HE | MarketResearch.biz
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The epigenetics market was valued at USD 2.3 billion in 2023 with a significant growth and is projected to reach at USD 12.7 billion by 2033 with a CAGR...
BioTech Breakthrough Awards Badge[1] copy.jpg
Garuda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
08 nov. 2023 08h03 HE | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
BioTech Breakthrough Awards Badge[1] copy.jpg
BioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards Program
08 nov. 2023 08h00 HE | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Outpace Bio to Present New Data on Tumor-restricted IL-12 Designed Leveraging OutSmart Technology to Enhance Solid Tumor T Cell Therapies at SITC 2023
31 oct. 2023 09h00 HE | Outpace Bio
Seattle, WA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a cell therapy company that is solving the major barriers to curing solid tumors with AI-powered protein design, today announced it will...
alberta.png
2024 Minister's Special Licence Auction (MSLA) Grant Program Open for Applications
17 oct. 2023 17h45 HE | Alberta Professional Outfitters Society
Intake of grant applications for projects that benefit wildlife stewardship in Alberta.
EdReports Launches I
EdReports Launches Inaugural Reviews of High School Science Curricula
06 juin 2023 10h30 HE | EdReports
Durham, North Carolina, June 06, 2023 (GLOBE NEWSWIRE) -- EdReports, a nonprofit that provides free reviews of instructional materials, published its first set of reviews of high school science...
Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub & Collaborations with Leading Experts in Protein Design & Cancer Immunotherapy
22 mai 2023 08h00 HE | Outpace Bio
Seattle, WA, May 22, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced the...
outpace logo.png
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
18 mai 2023 08h00 HE | Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...